Thank you for visiting our site.
Lilly’s Open Innovation Drug Discovery (OIDD) program will be retired over the next several months. During this time, Lilly will continue to support the institutions and investigators participating in this program. Lilly remains committed to external innovation, which is part of our core strategy. We will use the experiences and learnings from OIDD as we look for ways to further evolve and improve our external innovation efforts.
If you have a question, please send us an